Chemotherapeutic and antibiotic drugs in the management of infections of the urinary tract☆
References (98)
- et al.
Pyelonephritis. Correlation of clinical andpathologic observations in the antibiotic era
M. Clin. North America
(1955) - et al.
Pyelitis in toxemias of pregnancy
Am. J. Obst. & Gynec.
(1936) Experimental studies on urinary infections of the bacillary type
J. Urol.
(1934)The effect of pH on the growth of bacteria in urine
J. Urol.
(1940)The ketogenic diet. Nature of the bactericidal agent
Lancet
(1933)- et al.
Neoarsphenamine in the treatment of urinary infections
J. Urol.
(1940) - et al.
Mandelic acid: its therapeutic value
Am. J. Surg.
(1938) - et al.
The treatment of urinary infections with mandelamine (methenamine mandelate). A clinical study of 200 cases
J. Urol.
(1946) - et al.
The treatment of E. coli urinary infections with sulfathalidine (phthalylsulfathiazole)
J. Urol.
(1948) - et al.
The clinical use of Nu-445 (gantrisin) in the treatment of urinary tract infections. A report of 100 cases
J. Urol.
(1950)
Incidence of antibiotic-resistant staphylococci in a hospital
Lancet
Streptomycin treatment of urinary tract infections with special reference to the use of alkali
Am. J. Med.
The treatment of bacillary urinary infections with chloromycetin
J. Urol.
The polymyxins. A review and assessment
Am. J. Med.
Effect of combined therapy on emergence of drug resistant bacteria in urinary tract infections. Observations on origin of resistant strains
J. Urol.
Penicillin-resistant staphylococcal infection in a maternity hospital
Lancet
Pyelonephritis—its relation to vascular lesions and to arterial hypertension
Medicine
The differential diagnosis of Bright's disease: clinicopathological correlation
New England J. Med.
Antibacterial management of urinary tract infections
J. A. M. A.
Studies of chronic pyelonephritis
Pyelonephritis lenta
Ann. Int. Med.
Necrosis of renal papillae and acute pyelonephritis in diabetes mellitus
Arch. Int. Med.
The frequency and character of urinary tract infections in an unselected group of women
Ann. Int. Med.
Infections of the Kidney
Methenamine mandelate. Antimicrobial activity, absorption and excretion
Antibiotics & Chemother.
Studies in enterococci. Biochemical and serological classification with some clinical remarks
Acta path. et microbiol. Scandinav. Suppl.
Coliform infections of the urinary tract
J. Clin. Path.
Bacterial aspects of chemotherapy of surgical urinary infections. Occurrence of resistance to chemotherapeutic agents
Acta chir. Scandinav.
Mandelic acid in the treatment of urinary infections
Lancet
Mandelic acid in the treatment of urinary infections
Am. J. Dis. Child.
Effect of chemotherapy and evaluation of sensitivity test in vitro in surgical urinary infections
Acta chir. Scandinav.
Bacteriophage in genito-urinary tract infections
Tr. Am. A. Genito-Urin. Surgeons
Escherichia coli bacilluria under ketogenic treatment
Studies of urinary acidifiers and antiseptics in relation to pyelitis and cystitis
Brit. J. Urol.
Infections of the urinary tract. II. Therapeutic results
Acta med. Scandinav.
Chemotherapy in nonspecific infections of the urinary tract
J. A. M. A.
On the treatment of infections of the urinary tract
Acta med. Scandinav.
Acidosis therapy in coli infections in the urinary tract
Acta med. Scandinav.
Results in the use of the ketogenic diet for urinary infections
Sulfacetamide and sulfadiazine therapy in urinary tract infections
South. M. J.
Sulphanilamide in the treatment of cystitis and pyelitis
Canad. M. A. J.
Sulfathiazole and the staphylococcus in urinary infections
Die Sulfonamidbehandlung der Harninfektion
Schweiz. med. Wchnschr.
Sulfathiazole. A clinical and in vitro study of its use in infections of the urinary tract
New England J. Med.
Sulfadiazine. Further clinical studies of its efficacy and toxic effects in 460 patients
Ann. Int. Med.
Sulfamerazine in the treatment of genitourinary infections. An analysis of 151 consecutive cases
New Orleans M. & S. J.
Gantrisin in the treatment of urinary infections
J. A. M. A.
Cited by (98)
The urobiome in men and women: a clinical review
2023, Clinical Microbiology and InfectionCitation Excerpt :Indeed, even these were underutilized because of high clinical cutoffs imposed many decades ago. Because bacterial counts below 105 CFU/mL were determined to be ‘negative’ [2], many laboratories essentially ignored bacteria with fewer than 103 or even 104 CFU/mL [3]. Launched in the 2000s, the Human Microbiome Project (https://hmpdacc.org) spurred interest in and more widespread use of molecular diagnostic techniques.
Epidemiologic, clinical and microbiological characteristics of nosocomial urinary infection in the spinal cord lesioned patient
2007, Actas Urologicas EspanolasMethenamine
2007, xPharm: The Comprehensive Pharmacology ReferenceManagement of urinary tract infection in patients with spinal cord injuries
2003, Clinical Microbiology and InfectionCitation Excerpt :Catheter-associated bacteriuria is the most common source of Gram-negative bacteremia in hospitalized patients, including those with SCI [29,30]. The concept of ‘significant bacteriuria’ for the diagnosis of UTIs was developed in the mid-1950s [31]. The traditional criterion of ≥105 CFU/mL has unacceptably low sensitivity for clinical diagnosis in SCI patients.
Bacterial Cystitis in Urogynaecology: An Update
2023, Textbook of Female Urology and Urogynecology: Clinical Perspectives
- ☆
Aided by grants from the U. S. Public Health Service, Lederle Laboratories Division, American Cyanamid Company and Chas. Pfizer & Co., Inc.
- 1
From the Thorndike Memorial Laboratory, Second and Fourth Medical Services (Harvard), Boston City Hospital and the Department of Medicine, Harvard Medical School, Boston, Mass.